| RetinalGenix Technologies Inc. (RTGN) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | ||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | ||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (128,219$) | (103,837$) | (139,072$) | (187,222$) | (186,390$) | (246,932$) | (165,745$) | (163,819$) | (290,025$) | 39,749$ | (123,810$) | (77,575$) | |||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 142,901$ | 103,090$ | 136,200$ | 184,873$ | 113,361$ | 239,108$ | 202,272$ | 214,205$ | 289,981$ | (41,618$) | 118,253$ | 85,007$ | |||||||||||||||||||||||||||||||||||||
| End Cash Position | 38$ | ||||||||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (128,219$) | (103,837$) | (139,072$) | (187,222$) | (186,390$) | (246,932$) | (165,745$) | (163,819$) | (290,025$) | 39,749$ | (123,810$) | (77,575$) | |||||||||||||||||||||||||||||||||||||